JAN’s (NYSE:JAN) Lock-Up Period Set To Expire Tomorrow

JAN’s (NYSE:JAN) lock-up period is set to expire on Wednesday, September 16th. JAN had issued 42,000,000 shares in its IPO on March 20th. The total size of the offering was $840,000,000 based on an initial share price of $20.00. After the expiration of JAN’s lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Analyst Ratings Changes

JAN has been the subject of several analyst reports. Royal Bank Of Canada raised their price objective on JAN from $30.00 to $34.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Wall Street Zen upgraded JAN from a “sell” rating to a “hold” rating in a research report on Saturday, August 8th. Scotiabank lifted their price objective on shares of JAN from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 2nd. UBS Group set a $29.00 price objective on shares of JAN in a research report on Thursday, June 18th. Finally, Weiss Ratings started coverage on shares of JAN in a research note on Thursday, August 6th. They issued a “hold (c-)” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $31.71.

JAN Trading Up 0.6%

Shares of NYSE JAN opened at $31.12 on Tuesday. The business has a 50 day simple moving average of $30.42. JAN has a fifty-two week low of $22.76 and a fifty-two week high of $32.83.

JAN (NYSE:JAN) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The company had revenue of $216.46 million during the quarter, compared to the consensus estimate of $203.32 million. JAN’s revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, equities research analysts anticipate that JAN will post 0.97 earnings per share for the current year.

JAN Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Friday, September 11th will be paid a dividend of $0.0475 per share. This represents a c) dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, September 11th.

Trending Headlines about JAN

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Janus Living’s board declared a monthly dividend of $0.0475 per common share for each month of the fourth quarter. The payout provides income visibility for shareholders and signals continued confidence in the company’s ability to support distributions. Janus Living Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
• Neutral Sentiment: The announced dividend equates to approximately $0.57 per share on an annualized basis, although investors should weigh the income benefit against the company’s recent earnings pressure. Janus Living’s latest quarterly EPS missed consensus, despite revenue growing 45.4% year over year, and management’s fiscal 2026 EPS guidance remains $0.95–$0.98.

Institutional Investors Weigh In On JAN

Several large investors have recently added to or reduced their stakes in the stock. Greenland Capital Management LP purchased a new stake in JAN in the 2nd quarter valued at about $575,000. Readystate Asset Management LP purchased a new position in shares of JAN during the second quarter worth approximately $1,724,000. WINTON GROUP Ltd bought a new stake in shares of JAN during the second quarter valued at approximately $2,985,000. Wellington Management Group LLP bought a new stake in shares of JAN during the second quarter valued at approximately $8,739,000. Finally, Engineers Gate Manager LP purchased a new stake in shares of JAN in the second quarter valued at approximately $15,274,000. 6.27% of the stock is owned by hedge funds and other institutional investors.

JAN Company Profile

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.